%D9%86%D9%8A%D8%AA%D8%B1%D9%88%D9%81%D9%88%D8%B1%D8%A7%D9%86%D8%AA%D9%88%D9%8A%D9%86%D9%86%DB%8C%D8%AA%D8%B1%D9%88%D9%81%D9%88%D8%B1%D8%A7%D9%86%D8%AA%D9%88%D8%A6%DB%8C%D9%86Category:NitrofurantoinNitroffwrantoinNitrofurantoinNitrofurantoinNitrofuranto%C3%ADna%D9%86%DB%8C%D8%AA%D8%B1%D9%88%D9%81%D9%88%D8%B1%D8%A7%D9%86%D8%AA%D9%88%D8%A6%DB%8C%D9%86NitrofurantoiiniNitrofuranNitrofuranto%C3%AFne%D7%A0%D7%99%D7%98%D7%A8%D7%95%D7%A4%D7%95%D7%A8%D7%90%D7%A0%D7%98%D7%95%D7%90%D7%99%D7%9FNitrofurantoinNitrofurantoina%E3%83%8B%E3%83%88%E3%83%AD%E3%83%95%E3%83%A9%E3%83%B3%E3%83%88%E3%82%A4%E3%83%B3Nitrofuranto%C3%AFne%E0%AC%A8%E0%AC%BE%E0%AC%87%E0%AC%9F%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%AB%E0%AD%81%E0%AC%B0%E0%AC%BE%E0%AC%A3%E0%AD%8D%E0%AC%9F%E0%AC%8F%E0%AC%A8NitrofurantoinaNitrofuranto%C3%ADnaNitrofurantoin%C4%83%D0%9D%D0%B8%D1%82%D1%80%D0%BE%D1%84%D1%83%D1%80%D0%B0%D0%BD%D1%82%D0%BE%D0%B8%D0%BDNitrofurantoinNitrofurantoin%D0%9D%D1%96%D1%82%D1%80%D0%BE%D1%84%D1%83%D1%80%D0%B0%D0%BD%D1%82%D0%BE%D1%97%D0%BDNitrofurantoinQ422669%E5%91%8B%E5%96%83%E5%A6%A5%E5%9B%A0
about
Nitrofurantoin Macrocrystals 3 Days Versus 7 Days in the Treatment of Women With Uncomplicated CystitisEfficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in AdultsExamination of the Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract InfectionsSuppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in WomenEstablish the Relationship Between Shift in Prescribing Pattern and Associated Shift in Sensitivity Pattern of Causative Microbes in UTI Patients in a Closed CommunityDoes Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for IncontinenceAsymptomatic Bacteriuria & Risk of Urinary Tract Infection in Renal TransplantsCranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic SurgeryOral Omadacycline vs. Oral Nitrofurantoin for the Treatment of CystitisNitrofurantoin and Urinary Tract Infections (UTIs)A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency DepartmentNitrofurantoin Prophylaxis During Catheter-managed Acute Urinary Retention After Pelvic Reconstructive SurgeryPatients Response to Early Switch To Oral:Osteomyelitis StudyEvaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary BladderAntibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary TractA Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL])Fed Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mgBioequivalence Study of Nitrofurantoin 100 mg Capsules Under Fed ConditionsAntibiotic Prophylaxis in Children With PyelonephritisFood Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100 mgFood Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mgINtravesical Antimicrobial Agents v STANDard Oral Antibiotics for the Treatment of Acute UTI in Women With rUTILactobacillus Reuteri for Treatment of Uncomplicated UTI in Pregnant WomenNitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic SurgeryStruvite Stones Antibiotic StudyTopical Umbilical Cord Care for the Prevention of Colonization and Invasive InfectionsUmbilical Cord Care for the Prevention of ColonizationShort Course Nitrofurantoin for Acute CystitisA Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)Treatment of Asymptomatic Bacteriuria in PregnancyEndourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2The Preventive Infection Role of One Week Antibiotics Before Minimally Invasive Upper Tract LithotomyAntibiotic Prophylaxis for Clean Intermittent CatheterisationComparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)
P4844
Clinical and experimental studies of distal axonopathy -- a frequent form of brain and nerve damage produced by environmental chemical hazardsClinical and experimental studies of distal axonopathy -- a frequent form of brain and nerve damage produced by environmental chemical hazardsNitrofurantoin-induced microangiopathic haemolytic anaemia and thrombocytopaenia in a patient with systemic lupus erythematosus[Antimicrobial resistance among E. coli in urinary specimens: prevalence data from three laboratories in Zurich between 1985 and 2010].Peripheral nerve toxic effects of nitrofurantoin.Monitoring of antibiotic resistance in bacteria isolated from laboratory animalsDecreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, CanadaAntimicrobial resistance of Staphylococcus aureus strains from patients with urinary tract infections in Yenagoa, Nigeria.Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections.Deletion of Abcg2 has differential effects on excretion and pharmacokinetics of probe substrates in rats.[Pulmonary toxicity resulting from the use of nitrofurantoin].Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis.Case-control study comparing de novo and daptomycin-exposed daptomycin-nonsusceptible Enterococcus infections.Sex, drugs, bugs, and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance.Antibiotic susceptibility of vancomyin and nitrofurantoin in Staphylococcus aureus isolated from burnt patients in Sulaimaniyah, Iraqi Kurdistan.[Choice of antibacterial drugs in urinary infection].Antibiotic susceptibility of organisms causing urinary tract infection in patients presenting to a teaching hospital.Antibiotic resistance in urinary tract infections in college students.Nitrofurantoin-induced immune-mediated lung and liver disease.Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns.High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden.Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problemsThe nature and epidemiology of OqxAB, a multidrug efflux pumpPrediction of the mode of interaction between monoterpenes and the nitroreductase from Enterobacter cloacae by docking simulationCaco-2 cells cytotoxicity of nifuroxazide derivatives with potential activity against Methicillin-resistant Staphylococcus aureus (MRSA)
P921
Q61934911-19118A3D-0593-46AE-BDBD-9D8A2AC8A30BQ61936993-FFA40CC6-6ADA-4575-8653-51033A9EA344Q61956654-AFDAE00F-8BEF-4B3C-8E47-280D072B5FA6Q61967361-75427EBD-4A07-4138-A04B-0191395F93EEQ61975654-621B17F7-8D06-4985-B728-F522961471C7Q62040689-5A1E104F-C2DA-4DAF-B0D4-08AF3749EAB1Q63063508-95909C06-7154-4D6F-B440-1E70F219EAC1Q63335087-ED908327-F1F1-4DF0-8618-E2B50AE2BAADQ63397147-D285D6BF-2DD7-41DE-8FCF-6EA13A4CF9AFQ63401805-CAAA0F5B-5309-4565-A139-72AFBE7BF7BFQ64046399-A2630CD8-C8F1-4BE8-97D2-6245CAF710FAQ64071336-72A2F000-E8BD-4CF1-85C6-25DDFFA18939Q64150155-135499CB-EBDA-47DC-A4CC-512D893D5947Q64220007-0792E858-63EE-4697-B957-BEF0CBB07178Q64220522-FEC7CE2F-EF5A-4FDF-BBF6-923610EE09CFQ64350303-33F34CCE-00D5-470C-9094-C309DD9C5BD9Q64398014-1480CA60-1FBB-4A6F-89E7-B3D6E98079B5Q64658825-82E9B70C-9123-492D-BFC9-F671B933CDD2Q64714388-EF3EAFD1-524B-4E6A-A882-7E784A770E62Q64716444-3C42D444-CC85-43A3-B28F-4CA8B8545417Q64720820-AAC08612-91FD-402D-BBDA-77BFBBB3B1E7Q64720853-1E744E52-4653-4D74-B53D-24886568D49FQ64790649-A2BEA15F-8DB9-46FF-8E5B-8D321110F4C3Q64807377-74740BD5-3F16-4BE0-828F-81BC941E542CQ64817414-8935D052-E240-4F8F-A209-A0DCA5438282Q65347174-65BB4A46-F655-44DA-AB3F-C4E3BEF946F4Q65361749-B03C4A43-DD8B-43F7-B5AC-7D59CBB78896Q65363521-916B37A9-B1A7-4B12-BB87-902F4D851C52Q65385871-55D92C68-7AF7-42EB-88CF-F653F2C6E46EQ66061487-9F9264E2-F113-4F83-8316-539C835B2E4BQ66081151-7FA16980-5608-4BA6-B021-A9CAE3EF020EQ66398595-C6B4F8B9-97B6-4CB8-9CDF-80761074D3A4Q66402370-A6504B48-8DF9-4D23-922E-03513BE45EDAQ67133707-6A8AABA4-CCD9-48BA-B0E6-29B3485C84B6Q79110894-0F3F379B-42BC-4A36-B0B6-7CA44F03B239
P4844
description
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
compositum chemicum
@la
name
Nitrofuran
@fo
Nitrofurantoiini
@fi
Nitrofurantoin
@de
Nitrofurantoin
@hu
Nitrofurantoin
@sh
Nitrofurantoin
@sr
Nitrofurantoin
@vi
Nitrofurantoina
@it
Nitrofurantoina
@pl
Nitrofurantoină
@ro
type
label
Nitrofuran
@fo
Nitrofurantoiini
@fi
Nitrofurantoin
@de
Nitrofurantoin
@hu
Nitrofurantoin
@sh
Nitrofurantoin
@sr
Nitrofurantoin
@vi
Nitrofurantoina
@it
Nitrofurantoina
@pl
Nitrofurantoină
@ro
altLabel
5-Nitrofurantoin
@cy
5-Nitrofurantoin
@en
C8H6N4O5
@it
Furabid
@nl
Furadantine
@nl
N-(5-Nitrofurfurylidene)-1-aminohydantoin
@cy
N-(5-Nitrofurfurylidene)-1-aminohydantoin
@en
Nitrofurantoine
@nl
SID11112186
@cy
SID11112186
@en
prefLabel
Nitrofuran
@fo
Nitrofurantoiini
@fi
Nitrofurantoin
@de
Nitrofurantoin
@hu
Nitrofurantoin
@sh
Nitrofurantoin
@sr
Nitrofurantoin
@vi
Nitrofurantoina
@it
Nitrofurantoina
@pl
Nitrofurantoină
@ro